Skip to main content
SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
9.75
-0.50 (-4.88%)
Mar 31, 2026, 5:15 PM GMT

SkinBioTherapeutics Cash Flow Statement

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Net Income
-0.7-2.88-2.84-2.79-1.43
Upgrade
Depreciation & Amortization
0.430.180.050.040.01
Upgrade
Loss (Gain) From Sale of Assets
0.03----
Upgrade
Stock-Based Compensation
--00.050.06
Upgrade
Other Operating Activities
-0.430.150.08-0.08-0.07
Upgrade
Change in Accounts Receivable
-0.750.17-0.050.13-0.2
Upgrade
Change in Inventory
0.010.10.09-0.12-
Upgrade
Change in Accounts Payable
0.17-0.440.020.10.07
Upgrade
Operating Cash Flow
-1.24-2.73-2.65-2.67-1.56
Upgrade
Capital Expenditures
-0.01-0.01-0.09--
Upgrade
Sale (Purchase) of Intangibles
-0.15-0.17-0.08-0.1-0.11
Upgrade
Other Investing Activities
-1.46-2.110--0
Upgrade
Investing Cash Flow
-1.62-2.3-0.17-0.1-0.11
Upgrade
Short-Term Debt Issued
-1.47---
Upgrade
Long-Term Debt Issued
0.95----
Upgrade
Total Debt Issued
0.951.47---
Upgrade
Long-Term Debt Repaid
-0.11-0.04-0.04-0.04-0
Upgrade
Net Debt Issued (Repaid)
0.841.43-0.04-0.04-0
Upgrade
Issuance of Common Stock
6.063.122.62-4.12
Upgrade
Other Financing Activities
-0.06-0.04-0.26--
Upgrade
Financing Cash Flow
6.834.512.32-0.044.12
Upgrade
Net Cash Flow
3.98-0.51-0.49-2.82.45
Upgrade
Free Cash Flow
-1.24-2.74-2.73-2.67-1.56
Upgrade
Free Cash Flow Margin
-26.76%-226.80%-2071.02%-3575.44%-
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.02-0.02-0.01
Upgrade
Cash Interest Paid
0.060.04---
Upgrade
Cash Income Tax Paid
-0.03-0.18-0.26-0.12-
Upgrade
Levered Free Cash Flow
-1.62-1.79-1.86-1.85-1.17
Upgrade
Unlevered Free Cash Flow
-1.56-1.76-1.85-1.84-1.17
Upgrade
Change in Working Capital
-0.57-0.170.050.11-0.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.